Combined Treatment with Polynucleotides and Hyaluronic Acid Improves Tissue Repair in Experimental Colitis.

CD20 CD3 CD44 IBD colitis hyaluronic acid polynucleotides

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
20 Oct 2020
Historique:
received: 28 08 2020
revised: 16 10 2020
accepted: 18 10 2020
entrez: 23 10 2020
pubmed: 24 10 2020
medline: 24 10 2020
Statut: epublish

Résumé

Inflammatory bowel diseases (IBDs) are chronic conditions that can benefit from the combined treatment of adenosine receptor agonists and hyaluronic acid (HA), which, binding the CD44, has pro-survival effects. Therefore, this study investigated the effects of a mixture of polynucleotides and HA in an experimental model of dinitrobenzenesulfonic acid (DNBS)-induced colitis. A group of 40 rats received a single intra-colonic instillation of DNBS, and after 6 h, animals were randomized to receive daily: (i) saline solution; (ii) polynucleotides (Poly; 8 mg/kg); (iii) polynucleotides (8 mg/kg) plus hyaluronic acid (HA; 15 mg/kg); and (iv) hyaluronic acid (HA; 15 mg/kg). Rats in the control group (

Identifiants

pubmed: 33092298
pii: biomedicines8100438
doi: 10.3390/biomedicines8100438
pmc: PMC7589719
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Pharmacol Res. 2018 Jun;132:220-231
pubmed: 29287688
Mediators Inflamm. 2015;2015:591572
pubmed: 25873765
Cells. 2019 Sep 12;8(9):
pubmed: 31547322
Br J Pharmacol. 2010 Aug;160(7):1573-6
pubmed: 20649560
J Leukoc Biol. 2006 Mar;79(3):574-85
pubmed: 16387843
Free Radic Biol Med. 2002 Aug 1;33(3):311-22
pubmed: 12126753
J Immunol. 2006 Sep 1;177(5):2765-9
pubmed: 16920910
J Leukoc Biol. 2004 Jan;75(1):127-34
pubmed: 14525968
Polymers (Basel). 2018 Jun 25;10(7):
pubmed: 30960626
Front Immunol. 2016 Feb 08;7:39
pubmed: 26904028
Front Pharmacol. 2017 Jan 10;7:537
pubmed: 28119612
J Neuroinflammation. 2018 Sep 14;15(1):264
pubmed: 30217164
J Pharmacol Exp Ther. 2010 Nov;335(2):434-42
pubmed: 20668053
J Clin Endocrinol Metab. 2014 May;99(5):E746-53
pubmed: 24483158
Inflamm Bowel Dis. 2014 Dec;20(12):2433-49
pubmed: 25208108
FASEB J. 2000 Oct;14(13):2065-74
pubmed: 11023991
Front Pharmacol. 2018 May 29;9:506
pubmed: 29896101
Oxid Med Cell Longev. 2017;2017:6341671
pubmed: 29379585
Lancet. 2007 May 12;369(9573):1641-57
pubmed: 17499606
Dig Liver Dis. 2014 Apr;46(4):330-4
pubmed: 24462118
Molecules. 2017 May 30;22(6):
pubmed: 28556814
Oxid Med Cell Longev. 2018 Aug 29;2018:4285694
pubmed: 30228855
J Vis Exp. 2014 Feb 27;(84):e51297
pubmed: 24637969
Inflamm Allergy Drug Targets. 2009 Jul;8(3):208-20
pubmed: 19601881
Anal Biochem. 1979 Jun;95(2):351-8
pubmed: 36810
Gastroenterology. 1992 Jan;102(1):18-27
pubmed: 1309357
Ann Neurol. 2001 Jun;49(6):727-35
pubmed: 11409424
J Pharmacol Methods. 1985 Nov;14(3):157-67
pubmed: 2997548
J Pharmacol Exp Ther. 2001 Jan;296(1):99-105
pubmed: 11123368
J Leukoc Biol. 2001 Nov;70(5):821-9
pubmed: 11698503
Int J Cell Biol. 2015;2015:563818
pubmed: 26448754
Pathobiology. 2002-2003;70(3):184-9
pubmed: 12571424
J Pharmacol Exp Ther. 2006 Apr;317(1):172-80
pubmed: 16339914
Front Pharmacol. 2016 Aug 23;7:273
pubmed: 27601997
J Immunol. 1985 Aug;135(2):1366-71
pubmed: 2989364
Eur J Pharmacol. 2010 Dec 15;649(1-3):376-81
pubmed: 20868668
J Environ Public Health. 2014;2014:326845
pubmed: 25328531
Nat Cell Biol. 2002 May;4(5):E131-6
pubmed: 11988758
J Exp Med. 1983 Oct 1;158(4):1160-77
pubmed: 6311934
Eur J Pharmacol. 2016 Oct 15;789:152-162
pubmed: 27450484
Neuromolecular Med. 2015 Jun;17(2):192-201
pubmed: 25893744
J Zhejiang Univ Sci B. 2011 Sep;12(9):712-9
pubmed: 21887846
Inflamm Res. 2017 May;66(5):389-398
pubmed: 28238167
N Engl J Med. 2002 Aug 8;347(6):417-29
pubmed: 12167685
J Immunol. 2007 Aug 1;179(3):1884-92
pubmed: 17641055
Scand J Gastroenterol. 1992 Jul;27(7):529-37
pubmed: 1641579
Front Immunol. 2015 May 13;6:224
pubmed: 26029210
Nat Rev Drug Discov. 2008 Sep;7(9):759-70
pubmed: 18758473
Gastroenterology. 2011 May;140(6):1827-1837.e2
pubmed: 21530749
World J Gastroenterol. 2016 Dec 21;22(47):10275-10286
pubmed: 28058009
Gastroenterology. 2005 Jul;129(1):26-33
pubmed: 16012931
Front Pharmacol. 2017 Sep 05;8:558
pubmed: 28928654

Auteurs

Giovanni Pallio (G)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Alessandra Bitto (A)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Antonio Ieni (A)

Department of Human Pathology and Evolutive Age "Gaetano Barresi", University of Messina, Via C. Valeria, 98125 Messina, Italy.

Natasha Irrera (N)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Federica Mannino (F)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Socrate Pallio (S)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Domenica Altavilla (D)

Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Francesco Squadrito (F)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Carmelo Scarpignato (C)

Department of Health Sciences, United Campus of Malta, Msida MSD 2080, Malta.
Faculty of Medicine, Chinese University of Hong Kong, ShaTin, Hong Kong.

Letteria Minutoli (L)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Classifications MeSH